A novel prognostic signature based on smoking-associated genes for predicting prognosis and immune microenvironment in nsclc smokers

HIGHLIGHTS

• What: To sum up, we built a prognostic risk model based on seven prognostic smoking-related genes, which can accurately evaluate the prognosis, immunotherapy, drug sensitivity and tumor microenvironment of NSCLC patients.
• Who: A novel prognostic signature et al. from the (UNIVERSITY) have published the research: RESEARCH Open Access, in the Journal: (JOURNAL)
• How: Univariate (Fig 7C) and multivariate (Fig 7D) cox regression analysis result showed that the 7-gene risk signature is an independent prognostic factor for predicting the OS of patients in external verification. Last but not least the authors conducted . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.